146 related articles for article (PubMed ID: 35436678)
21. Recurrent duplication of Xq27-qter in hematological malignancies revealed by multicolor fluorescence in situ hybridization and multicolor banding.
MacKinnon RN; Zordan A; Campbell LJ
Cancer Genet Cytogenet; 2005 Sep; 161(2):125-9. PubMed ID: 16102582
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetics in haematological malignancy: current technology and future prospects.
Kearney L; Horsley SW
Chromosoma; 2005 Sep; 114(4):286-94. PubMed ID: 16003502
[TBL] [Abstract][Full Text] [Related]
24. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
[TBL] [Abstract][Full Text] [Related]
25. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
26. Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.
Jeon Y; Kim SY; Kim M; Park HK; Lee SH; See CJ; Kwon J; Lee DS
Blood Cells Mol Dis; 2014 Apr; 52(4):208-13. PubMed ID: 24211232
[TBL] [Abstract][Full Text] [Related]
27. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
[TBL] [Abstract][Full Text] [Related]
28. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
Struski S; Luquet I
Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
[No Abstract] [Full Text] [Related]
29. Microfluidic channel-assisted screening of hematopoietic malignancies.
Mughal F; Baldock SJ; Karimiani EG; Telford N; Goddard NJ; Day PJ
Genes Chromosomes Cancer; 2014 Mar; 53(3):255-63. PubMed ID: 24339206
[TBL] [Abstract][Full Text] [Related]
30. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract][Full Text] [Related]
31. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
32. Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer.
Horii R; Matsuura M; Iwase T; Ito Y; Akiyama F
Breast Cancer; 2014 Sep; 21(5):598-604. PubMed ID: 23307494
[TBL] [Abstract][Full Text] [Related]
33. [Fluorescence in situ hybridization in hematology].
Milosević I; Popović S; Urosević I
Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
[No Abstract] [Full Text] [Related]
34. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
35. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
Lafage-Pochitaloff M
Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
[No Abstract] [Full Text] [Related]
36. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
37. [FISH, interphase cytogenetics, gene rearrangements].
Taniwaki M
Rinsho Ketsueki; 1998 Feb; 39(2):75-7. PubMed ID: 9545801
[No Abstract] [Full Text] [Related]
38. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
[TBL] [Abstract][Full Text] [Related]
39. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
40. Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors.
Zito Marino F; Brunelli M; Rossi G; Calabrese G; Caliò A; Nardiello P; Martignoni G; Squire JA; Cheng L; Massi D; Franco R
Expert Rev Mol Diagn; 2021 Feb; 21(2):161-173. PubMed ID: 33593207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
